Global Osteoporosis Therapeutics Market to 2027 - Rising Prevalence of Osteoporosis in Post-menopausal Women Propels Market Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Osteoporosis Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The global market for Osteoporosis Therapeutics estimated at US$11.5 Billion in the year 2020, is projected to reach a revised size of US$14 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027.

Bisphosphonates, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parathyroid Hormone Therapy segment is readjusted to a revised 2.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 5.4% CAGR

The Osteoporosis Therapeutics market in the U.S. is estimated at US$4.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$758.8 Million by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Calcitonin Segment to Record 2.8% CAGR

In the global Calcitonin segment, USA, Canada, Japan, China and Europe will drive the 2.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.4 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$573.6 Million by the year 2027.

Select Competitors (Total 53 Featured) -

• Alergan Plc.
• Amgen, Inc.
• Chugai pharmaceutical
• Daiichi Sankyo Co., Ltd.
• Egalet Corporation
• Eisai Co., Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.;

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• A Prelude to Osteoporosis
• Growing Geriatric Population and Rising Incidence of Osteoporosis Drive the Global Osteoporosis Market
• Developed Regions Dominate the Global Market, Developing to Witness Fastest Growth
• Bisphosphonates - The Largest Category of Drugs for Treating Osteoporosis
• Approved Drugs for Treatment of Osteoporosis
• Select Recent Osteoporosis Drug Approvals
• Osteoporosis Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
• Sales of Leading Osteoporosis Therapeutics: 2018
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Growing Incidence of Osteoporosis Augurs Well for Osteoporosis Therapeutics
• Global Osteoporosis Prevalence by Country/Region (2012 & 2022P): Number of People with Osteoporosis in Millions for US, EU, Japan, China and India
• % of Women Affected by Osteoporosis
• Osteoporosis - Factsheet
• Osteoporosis in Men
• Rising Geriatric Population and the Associated Bone Health Issues to Drive Market Gains
• Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
• Rising Prevalence of Osteoporosis in Post-menopausal Women Propels Market Growth
• Changing Lifestyle Impacting Bone Health
• Recommended Daily Intake of Calcium and Vitamin D
• Increasing Awareness Related to Osteoporosis Care
• New Product Launches Foster Market Growth

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/8pbp2f